1st Quarter - Report

AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.460, Patients' Access to Treatments Act of 2013: Establish cost-sharing limits for health plans that cover prescription drugs; Coverage and appropriate use of telemedicine; Extension for 2014 CEHRT criteria and allowing greater flexibility in meeting MU criteria; FDA regarding their review process of clinical trials for multiple sclerosis; DEA regarding the schedule II classification of DaTscan

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
DANEEN P GROOMS —
BRUCE SIGSBEE —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 460 (113th)

Medicare/Medicaid MMM

H.R. 574, Medicare Physician Payment Innovation Act of 2013: Medicare physician payment-sustainable growth rate (SGR) reform S. 577 / HR 1180, Resident Physician Shortage Reduction Act of 2013: Graduate medical education-residency training S. 755/ H.R. 1838, Enhanced Access to Medicaid Services Act of 2013: Amends title XIX (Medicaid) of the Social Security Act H.R. 1173, Personalize Your Care Act of 2013: Voluntary advance care planning consultation in MedicareH.R. 1201, Training Tomorrow's Doctors Today Act: Graduate medical education-residency training S. 2000/ H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Medicare physician payment-sustainable growth rate (SGR) reform S. 2046 / H.R. 4035: To amend title XVIII of the Social Security Act to provide Medicare beneficiaries coordinated care and greater choice with regard to accessing hearing health services and benefits. S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014: Medicare physician payment-sustainable growth rate (SGR) reform H.R. 2810, Medicare Patient Access and Quality Improvement Act: Medicare physician payment-sustainable growth rate (SGR) reform H.R. 4106, Saving Lives, Saving Costs Act: Provides safe harbors for practitioners following evidence based guidelines H.R. 4302, Protecting Access to Medicare Act of 2014: Changes to Medicare physician payment-sustainable growth rate (SGR) formula Preservation of the in-office ancillary exception to the Stark law; ACO exclusivity issues; Protected class status criteria; ICD 10 transition and implementation; Commented on CMS RFI on specialty practitioner payment model opportunities.

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
DANEEN P GROOMS —
BRUCE SIGSBEE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 577 (113th), H.R. 1173 (113th), S. 755 (113th), H.R. 4106 (113th), H.R. 2810 (113th), S. 2110 (113th), H.R. 4015 (113th), S. 2046 (113th), H.R. 4035 (113th), H.R. 4302 (113th), H.R. 1838 (113th), H.R. 574 (113th), H.R. 1180 (113th), S. 2000 (113th)

Budget/Appropriations BUD

VA Epilepsy Centers of Excellence, NIH, Alzheimers Research, and the pediatric loan repayment program

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
BRUCE SIGSBEE —

Contacted: Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.